CD4-specific CAR T Cells (CD4 CAR T Cells) for Relapsed/Refractory T Cell Malignancies

计划入组 12 人 · 首次发布于 2019 年 11 月 14 日

Phase 2 Estimation Study of Fixed Dose Drugs Combination Type of Polypill

计划入组 103 人 · 首次发布于 2024 年 9 月 19 日

CD7 CAR-T Cells in T-cell Lymphoma/Leukemia

计划入组 20 人 · 首次发布于 2022 年 11 月 17 日

MAR-8644

MAR-531

MAR-99

STEM CELLS ARABIA

Jordan

Hospital del Mar

Spain

PHARMA MAR SA

Spain

Multi-Antigen T Cell Therapy Shows 84.6% Disease Control Rate in Pancreatic Cancer Phase 1/2 Trial

Marker Therapeutics Initiates First Off-the-Shelf T Cell Therapy Trial with Promising Early Safety Data

Lymphodepletion Enhances MAR-T Cell Therapy Efficacy in Lymphoma Patients, Marker Therapeutics Reports